Exane Derivatives’s Thermo Fisher Scientific TMO Stock Holding History

Exane Derivatives’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,766	Closed	-$1.04M	–	934
2022 Q1	$1.04M	Buy	+1,766	New	+$1.01M	0.29%	87
2021 Q4	–	Sell	-4,194	Closed	-$2.4M	–	983
2021 Q3	$2.4M	Buy	4,194 +93	+2%	+$51K	0.58%	31
2021 Q2	$2.11M	Buy	4,101 +643	+19%	+$303K	0.48%	39
2021 Q1	$1.58M	Sell	3,458 -989	-22%	-$472K	0.45%	46
2020 Q4	$2.07M	Buy	4,447 +682	+18%	+$320K	0.61%	31
2020 Q3	$1.66M	Sell	3,765 -31	-0.8%	-$12.8K	0.48%	43
2020 Q2	$1.38M	Buy	3,796 +868	+30%	+$291K	0.37%	76
2020 Q1	$830K	Sell	2,928 -852	-23%	-$269K	0.23%	88
2019 Q4	$1.27M	Sell	3,780 -240	-6%	-$72.8K	0.23%	99
2019 Q3	$1.17M	Buy	4,020 +1,856	+86%	+$531K	0.21%	92
2019 Q2	$635K	Buy	2,164 +1,817	+524%	+$500K	0.11%	145
2019 Q1	$94.9K	Buy	347 +173	+99%	+$43.1K	0.02%	297
2018 Q4	$38.9K	Buy	+174	New	+$40.8K	0.01%	384
2017 Q1	–	Sell	-2,558	Closed	-$361K	–	677
2016 Q4	$361K	Sell	2,558 -24,857	-91%	-$3.66M	0.07%	178
2016 Q3	$4.36M	Buy	27,415 +18,899	+222%	+$2.91M	0.65%	45
2016 Q2	$1.26M	Buy	+8,516	New	+$1.26M	0.21%	74
2015 Q4	–	Sell	-330	Closed	-$40.4K	–	561
2015 Q3	$40.4K	Buy	+330	New	+$43K	0.01%	287

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's TMO Position: Q2 2022 in Review

Exane Derivatives sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 1,766 shares — an estimated $1.04M sold.

Exane Derivatives first reported a position in TMO in Q3 2015 and held it in 17 quarters. The position peaked at $4.36M in Q3 2016. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Exane Derivatives reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,766 Thermo Fisher Scientific shares in Q2 2022, an estimated $1.04M.
Exane Derivatives first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 17 quarters.
Exane Derivatives's Thermo Fisher Scientific position peaked at $4.36M in Q3 2016.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.